Chika Ifeanyi Chukwuma

Dr. Chika Ifeanyi Chukwuma

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
MMMotlalepula Matsabisa
Motlalepula Matsabisa
MIMohammed Auwal Ibrahim
Mohammed Auwal Ibrahim
OEOchuko L. Erukainure
Ochuko L. Erukainure
MCMatimbha H. Chabalala
Matimbha H. Chabalala
SIShahidul Islam
Shahidul Islam

26 January 2015 in Food & Function
Verified
Journal Article
Closed access
PDF file
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
Shahidul IslamShahidul Islam
Shahidul Islam
The present study investigated the possible mechanism(s) behind the effects of xylitol on carbohydrate digesting enzymes activity, muscle glucose uptake and intestinal glucose absorption using in vitro, ex vivo and in vivo experimental models. The effects of increasing concentrations of xylitol (2.5%–40% or 164.31 mM–2628.99 mM) on alpha amylase and alpha glucosidase activity in vitro and intestinal glucose absorption and muscle glucose uptake were investigated under ex vivo conditions. Additionally, the effects of an oral bolus dose of xylitol (1 g per kg BW) on gastric emptying and intestinal glucose absorption and digesta transit in the different segments of the intestinal tract were investigated in normal and type 2 diabetic rats at 1 hour after dose administration, when phenol red was used as a recovery marker. Xylitol exhibited concentration-dependent inhibition of alpha amylase (IC50 = 1364.04 mM) and alpha glucosidase (IC50 = 1127.52 mM) activity in vitro and small intestinal glucose absorption under ex vivo condition. Xylitol also increased dose dependent muscle glucose uptake with and without insulin, although the uptake was not significantly affected by the addition of insulin. Oral single bolus dose of xylitol significantly delayed gastric emptying, inhibited intestinal glucose absorption but increased the intestinal digesta transit rate in both normal and diabetic rats compared to their respective controls. The data of this study suggest that xylitol reduces intestinal glucose absorption via inhibiting major carbohydrate digesting enzymes, slowing gastric emptying and fastening the intestinal transit rate, but increases muscle glucose uptake in normal and type 2 diabetic rats.

2 August 2017 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
RMRamgopal Mopuri
Ramgopal Mopuri
SNSavania Nagiah
Savania Nagiah
ACAnil Amichund Chuturgoon
Anil Amichund Chuturgoon
Shahidul IslamShahidul Islam
Shahidul Islam

1 May 2020 in Pharmacological Research
Verified
Journal Article
Closed access
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
SMSamson S. Mashele
Samson S. Mashele
KEKenneth C. Eze
Kenneth C. Eze
GMGodfrey R. Matowane
Godfrey R. Matowane
SIShahidul Md. Islam
Shahidul Md. Islam
LRLimpho M. Ramorobi
Limpho M. Ramorobi

1 February 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
OEOchuko Lucky Erukainure
Ochuko Lucky Erukainure
RHRahman M. Hafizur
Rahman M. Hafizur
NKNurul Kabir
Nurul Kabir
MCM. Iqbal Choudhary
M. Iqbal Choudhary
OAOlubunmi Atolani
Olubunmi Atolani
SIShahidul Islam
Shahidul Islam
Type 2 diabetes is the most prominent of all diabetes types, contributing to global morbidity and mortality. Availability and cost of treatment with little or no side effect especially in developing countries, remains a huge burden. This has led to the search of affordable alternative therapies especially from medicinal plants. In this study, the antidiabetic effect of the methanolic extract, dichloromethane (DCM), butanol (BuOH) and aqueous fractions of Clerodendrum volubile leaves were investigated in type 2 diabetic rats for their effect on glucose homeostasis, serum insulin level and hepatic biomarkers, lipid profile, pancreatic redox balance and Ca2+ levels, and β-cell distribution and function. The DCM was further fractionated to isolate the active compounds, biochanin and 5,7,4′-trimethoxykaempferol. They were investigated for their toxicity and ADMET properties, α-glucosidase and angiotensin I converting enzyme (ACE) inhibitory activities in silico. There were significant (p < 0.05) decrease in blood glucose, cholesterol, LDL-C, vLDL-C, triglyceride, AST and ALT levels in all treated groups, with DCM fraction showing the best activity. All treated rats showed significantly (p < 0.05) improved anti-oxidative activities. Treatment with the DCM fraction led to significant (p < 0.05) increased serum insulin and pancreatic Ca2+ levels, as well as improved β-cell distribution and function. DCM fraction also showed improved glucose tolerance. DCM fraction dose-dependently inhibited ACE activity. The toxicity class of the isolated compounds was predicted to be 5. They were also predicted to be potent inhibitors of cytochrome P (CYPs) 1A2, 2D6 and 3A4. They docked well with α-glucosidase and ACE. These results indicate the therapeutic potential of the plant against type 2 diabetes, with the DCM fraction being the most potent which may be attributed to the isolated flavones. It further suggests antihypertensive potentials of the DCM fraction. However, inhibition of CYPs by the flavones may suggest caution in usage with other prescribed drugs metabolized by these enzymes.

13 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
LMLondiwe Simphiwe Mbatha
Londiwe Simphiwe Mbatha
JAJude Akinyelu
Jude Akinyelu
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
MMMduduzi Paul Mokoena
Mduduzi Paul Mokoena
TKTukayi Kudanga
Tukayi Kudanga
Cancer and COVID-19 have been deemed as world health concerns due to the millions of lives that they have claimed over the years. Extensive efforts have been made to develop sophisticated, site-specific, and safe strategies that can effectively diagnose, prevent, manage, and treat these diseases. These strategies involve the implementation of metal nanoparticles and metal oxides such as gold, silver, iron oxide, titanium oxide, zinc oxide, and copper oxide, formulated through nanotechnology as alternative anticancer or antiviral therapeutics or drug delivery systems. This review provides a perspective on metal nanoparticles and their potential application in cancer and COVID-19 treatments. The data of published studies were critically analysed to expose the potential therapeutic relevance of green synthesized metal nanoparticles in cancer and COVID-19. Although various research reports highlight the great potential of metal and metal oxide nanoparticles as alternative nanotherapeutics, issues of nanotoxicity, complex methods of preparation, biodegradability, and clearance are lingering challenges for the successful clinical application of the NPs. Thus, future innovations include fabricating metal nanoparticles with eco-friendly materials, tailor making them with optimal therapeutics for specific disease targeting, and in vitro and in vivo evaluation of safety, therapeutic efficiency, pharmacokinetics, and biodistribution.